Adenosinergic System Involvement in Ischemic Stroke Patients’ Lymphocytes
Open Access
- 25 April 2020
- Vol. 9 (5), 1072
- https://doi.org/10.3390/cells9051072
Abstract
Adenosine modulates many physiological processes through the interaction with adenosine receptors (ARs) named as A1, A2A, A2B, and A3ARs. During ischemic stroke, adenosine mediates neuroprotective and anti-inflammatory effects through ARs activation. One of the dominant pathways generating extracellular adenosine involves the dephosphorylation of ATP by ecto-nucleotidases CD39 and CD73, which efficiently hydrolyze extracellular ATP to adenosine. The aim of the study is to assess the presence of ARs in lymphocytes from ischemic stroke patients compared to healthy subjects and to analyze changes in CD39 and CD73 expression in CD4+ and CD8+ lymphocytes. Saturation binding experiments revealed that A2AARs affinity and density were significantly increased in ischemic stroke patients whilst no differences were found in A1, A2B, and A3ARs. These results were also confirmed in reverse transcription (RT)-polymerase chain reaction (PCR) assays where A2AAR mRNA levels of ischemic stroke patients were higher than in control subjects. In flow cytometry experiments, the percentage of CD73+ cells was significantly decreased in lymphocytes and in T-lymphocyte subclasses CD4+ and CD8+ obtained from ischemic stroke patients in comparison with healthy individuals. These data corroborate the importance of the adenosinergic system in ischemic stroke and could open the way to more targeted therapeutic approaches and biomarker development for ischemic stroke.This publication has 51 references indexed in Scilit:
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulatedEuropean Journal of Immunology, 2013
- Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microgliaJournal of Neuroinflammation, 2013
- Autoimmunity in CD73/Ecto-5′-Nucleotidase Deficient Mice Induces Renal InjuryPLOS ONE, 2012
- Tissue-Resident Ecto-5′ Nucleotidase (CD73) Regulates Leukocyte Trafficking in the Ischemic BrainThe Journal of Immunology, 2012
- Generation of anti‐inflammatory adenosine byleukocytes is regulated by TGF‐βEuropean Journal of Immunology, 2011
- A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase releaseArthritis Research & Therapy, 2011
- IFN‐β protects from vascular leakage via up‐regulation of CD73European Journal of Immunology, 2007
- Regulation of A2A adenosine receptor expression and functioning following permanent focal ischemia in rat brainJournal of Neurochemistry, 2007
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007